Cardinal Health - CAH Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last twelve months. There are currently 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CAH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CAH, but not buy additional shares or sell existing shares.
View CAH analyst ratings or view top-rated stocks.

11 Wall Street research analysts have issued 12-month target prices for Cardinal Health's shares. Their CAH share price forecasts range from $67.00 to $94.00. On average, they anticipate the company's stock price to reach $80.64 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price.
View analysts price targets for CAH or view top-rated stocks among Wall Street analysts.

Cardinal Health's stock was trading at $76.87 at the beginning of 2023. Since then, CAH shares have decreased by 7.6% and is now trading at $71.05.
View the best growth stocks for 2023 here.

Cardinal Health saw a decrease in short interest in February. As of February 28th, there was short interest totaling 4,960,000 shares, a decrease of 21.3% from the February 13th total of 6,300,000 shares. Based on an average daily volume of 2,680,000 shares, the days-to-cover ratio is presently 1.9 days. Approximately 1.9% of the company's stock are short sold.
View Cardinal Health's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our CAH earnings forecast.

Cardinal Health, Inc. (NYSE:CAH) posted its earnings results on Thursday, February, 2nd. The company reported $1.32 earnings per share for the quarter, topping analysts' consensus estimates of $1.13 by $0.19. The business earned $51.47 billion during the quarter, compared to analysts' expectations of $50.03 billion. Cardinal Health had a negative trailing twelve-month return on equity of 101.28% and a negative net margin of 0.66%. The firm's quarterly revenue was up 13.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.27 earnings per share.
Read the conference call transcript.

Cardinal Health declared a quarterly dividend on Friday, February 10th. Shareholders of record on Monday, April 3rd will be paid a dividend of $0.4957 per share on Saturday, April 15th. This represents a $1.98 annualized dividend and a dividend yield of 2.79%. The ex-dividend date is Friday, March 31st.
Read our dividend analysis for CAH.

ETFs with the largest weight of Cardinal Health (NYSE:CAH) stock in their portfolio include First Trust Nasdaq Pharmaceuticals ETF (FTXH), LeaderShares AlphaFactor Tactical Focused ETF (LSAT), SEI Enhanced U.S. Large Cap Value Factor ETF (SEIV), Invesco DWA Consumer Cyclicals Momentum ETF (PEZ), SRH U.S. Quality ETF (SRHQ), AAM S&P 500 High Dividend Value ETF (SPDV), Alpha Architect U.S. Quantitative Momentum ETF (QMOM) and First Trust Dorsey Wright Momentum & Value ETF (DVLU).

Cardinal Health (NYSE:CAH) pays an annual dividend of $1.98 per share and currently has a dividend yield of 2.85%. The company has been increasing its dividend for 37 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 36.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CAH will have a dividend payout ratio of 31.78% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CAH.

Cardinal Health issued an update on its FY 2023 earnings guidance on Thursday, February, 2nd. The company provided EPS guidance of $5.20-$5.50 for the period, compared to the consensus earnings per share estimate of $5.32. The company issued revenue guidance of -.

357 employees have rated Cardinal Health Chief Executive Officer Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Geode Capital Management LLC (2.08%), Price T Rowe Associates Inc. MD (1.94%), Morgan Stanley (1.78%), Amundi (1.63%), Arrowstreet Capital Limited Partnership (1.50%) and Norges Bank (1.11%). Insiders that own company stock include Michelle Brennan and Ola M Snow.
View institutional ownership trends.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $71.05.

Cardinal Health (NYSE:CAH) has a market capitalization of $18.31 billion and generates $181.36 billion in revenue each year. The company earns $-933,000,000.00 in net income (profit) each year or $5.45 on an earnings per share basis.

The company employs 46,500 workers across the globe.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The official website for the company is www.cardinalhealth.com. The company can be reached via phone at (614) 757-5000, via email at investor.relations@cardinalhealth.com, or via fax at 614-757-6000.